growth investing

In this episode, Marcus Today's Henry Jennings and Market Matters' James Gerrish analyse some of the market's hottest growth stocks.

Is there any value left after global growth's stellar run? You'll find out in this episode of Buy Hold Sell.

As part of their alternatives portfolio allocations. Learn more.

With the healthcare sector in a deep and prolonged downturn, valuations of public and private R&D stage companies are very attractive.

If we’ve learned anything in the last year, it’s to not underestimate the impact technology has on our future societies, or our portfolios.

The investing world has changed significantly since October last year. So it's time to update this series.

Leveraging expertise for expansive growth

Betashares and Global X put forward the ETFs they believe can deliver strong capital growth in 2024.

Each of these companies are widely tipped to have strong sales, solid ROE and healthy margins in the year ahead

The Nexus Of Quality and Growth